APERTO CVS PMCF Study

计划入组 6 人 · 首次发布于 2020 年 8 月 17 日

Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS)

计划入组 50 人 · 首次发布于 2023 年 11 月 18 日

Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS

计划入组 74 人 · 首次发布于 2020 年 4 月 1 日

CVS-16

CVS-2287

CVS-2589

CVS HEALTH CORPORATION

United States

CVS Health CDR (CAD Hedged)

United States

ROMAN HEALTH VENTURES INC.

United States

Ellipsis Health Raises $45M Series A to Launch Sage, AI Care Manager with Emotional Intelligence

Kouper Emerges from Stealth with $10M to Transform Hospital Discharge Care Transitions

CVS Health Expands Biosimilar Strategy, Dropping Amgen and Lilly Bone Disease Treatments from Formularies